Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review - PubMed (original) (raw)
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review
Monica Malta et al. PLoS Med. 2019.
Abstract
Background: Worldwide opioid-related overdose has become a major public health crisis. People with opioid use disorder (OUD) are overrepresented in the criminal justice system and at higher risk for opioid-related mortality. However, correctional facilities frequently adopt an abstinence-only approach, seldom offering the gold standard opioid agonist treatment (OAT) to incarcerated persons with OUD. In an attempt to inform adequate management of OUD among incarcerated persons, we conducted a systematic review of opioid-related interventions delivered before, during, and after incarceration.
Methods and findings: We systematically reviewed 8 electronic databases for original, peer-reviewed literature published between January 2008 and October 2019. Our review included studies conducted among adult participants with OUD who were incarcerated or recently released into the community (≤90 days post-incarceration). The search identified 2,356 articles, 46 of which met the inclusion criteria based on assessments by 2 independent reviewers. Thirty studies were conducted in North America, 9 in Europe, and 7 in Asia/Oceania. The systematic review included 22 randomized control trials (RCTs), 3 non-randomized clinical trials, and 21 observational studies. Eight observational studies utilized administrative data and included large sample sizes (median of 10,419 [range 2273-131,472] participants), and 13 observational studies utilized primary data, with a median of 140 (range 27-960) participants. RCTs and non-randomized clinical trials included a median of 198 (range 15-1,557) and 44 (range 27-382) participants, respectively. Twelve studies included only men, 1 study included only women, and in the remaining 33 studies, the percentage of women was below 30%. The majority of study participants were middle-aged adults (36-55 years). Participants treated at a correctional facility with methadone maintenance treatment (MMT) or buprenorphine (BPN)/naloxone (NLX) had lower rates of illicit opioid use, had higher adherence to OUD treatment, were less likely to be re-incarcerated, and were more likely to be working 1 year post-incarceration. Participants who received MMT or BPN/NLX while incarcerated had fewer nonfatal overdoses and lower mortality. The main limitation of our systematic review is the high heterogeneity of studies (different designs, settings, populations, treatments, and outcomes), precluding a meta-analysis. Other study limitations include the insufficient data about incarcerated women with OUD, and the lack of information about incarcerated populations with OUD who are not included in published research.
Conclusions: In this carefully conducted systematic review, we found that correctional facilities should scale up OAT among incarcerated persons with OUD. The strategy is likely to decrease opioid-related overdose and mortality, reduce opioid use and other risky behaviors during and after incarceration, and improve retention in addiction treatment after prison release. Immediate OAT after prison release and additional preventive strategies such as the distribution of NLX kits to at-risk individuals upon release greatly decrease the occurrence of opioid-related overdose and mortality. In an effort to mitigate the impact of the opioid-related overdose crisis, it is crucial to scale up OAT and opioid-related overdose prevention strategies (e.g., NLX) within a continuum of treatment before, during, and after incarceration.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Fig 1. Flow diagram of search strategy (2008–2019).
Similar articles
- Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
Bozinoff N, DeBeck K, Milloy MJ, Nosova E, Fairbairn N, Wood E, Hayashi K. Bozinoff N, et al. Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6. Drug Alcohol Depend. 2018. PMID: 30340144 Free PMC article. - Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
Pourtaher E, Gelberg KH, Fallico M, Ellendon N, Li S. Pourtaher E, et al. J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9. J Subst Use Addict Treat. 2024. PMID: 38081540 - Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.
Russell C, Nafeh F, Pang M, MacDonald SF, Derkzen D, Rehm J, Fischer B. Russell C, et al. BMC Public Health. 2022 Mar 4;22(1):436. doi: 10.1186/s12889-022-12685-0. BMC Public Health. 2022. PMID: 35246083 Free PMC article. - Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.
De Aquino JP, Parida S, Avila-Quintero VJ, Flores J, Compton P, Hickey T, Gómez O, Sofuoglu M. De Aquino JP, et al. Drug Alcohol Depend. 2021 Nov 1;228:109097. doi: 10.1016/j.drugalcdep.2021.109097. Epub 2021 Sep 22. Drug Alcohol Depend. 2021. PMID: 34601272 Free PMC article. Review. - Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS. Connock M, et al. Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. doi: 10.3310/hta11090. Health Technol Assess. 2007. PMID: 17313907 Review.
Cited by
- Provision of health care services related to substance use disorder in southern U.S. jails.
Rhodes Fortino B, Carda-Auten J, DiRosa EA, Rosen DL. Rhodes Fortino B, et al. J Subst Use Addict Treat. 2024 Mar;158:209234. doi: 10.1016/j.josat.2023.209234. Epub 2023 Dec 5. J Subst Use Addict Treat. 2024. PMID: 38061634 - Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives.
Michener PS, Evans EA, Ferguson WJ, Friedmann PD. Michener PS, et al. Addict Sci Clin Pract. 2024 Feb 12;19(1):10. doi: 10.1186/s13722-024-00440-2. Addict Sci Clin Pract. 2024. PMID: 38347634 Free PMC article. - "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder.
Michener PS, Bianchet E, Fox S, Evans EA, Friedmann PD. Michener PS, et al. Harm Reduct J. 2024 Jul 22;21(1):138. doi: 10.1186/s12954-024-01055-1. Harm Reduct J. 2024. PMID: 39034384 Free PMC article. - Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia.
Staton M, Pike E, Tillson M, Lofwall MR. Staton M, et al. J Community Psychol. 2024 Nov;52(8):997-1014. doi: 10.1002/jcop.23029. Epub 2023 Mar 17. J Community Psychol. 2024. PMID: 36930568 - Holyoke Early Access to Recovery and Treatment (HEART): A case study of a court-based intervention to reduce opioid overdose.
Bailey A, Evans EA. Bailey A, et al. J Ethn Subst Abuse. 2024 Oct-Dec;23(4):1039-1061. doi: 10.1080/15332640.2023.2172758. Epub 2023 Jan 30. J Ethn Subst Abuse. 2024. PMID: 36715087
References
- Government of Canada. Opioid-related harms and deaths in Canada. Ottawa: Government of Canada; 2019 [cited 2019 Jun 4]. https://www.canada.ca/en/health-canada/services/substance-abuse/prescrip....
- Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) 2017: admissions to and discharges from publicly-funded substance use treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2019 [cited 2019 Jun 4]. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/TEDS-2017.pdf.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous